Font Size: a A A

Preliminary Exploration Of Inhibition Of The Lytic Cycle Replication Of Kshv By Viral Infectivity Factor (vif) Of Human Immunodeficiency Virus Type 1 (hiv-1)

Posted on:2011-07-30Degree:MasterType:Thesis
Country:ChinaCandidate:P WangFull Text:PDF
GTID:2194330302955845Subject:Microbiology
Abstract/Summary:PDF Full Text Request
Background: Human immunodeficiency virus type 1 (HIV-1) infection significantly increases the risk of Kaposi's sarcoma (KS) occurrence in individuals infected with Kaposi's sarcoma-associated herpesvirus (KSHV). KSHV infection appeared to be necessary but some cofactors also played important roles in KS pathogenesis. We and others identified that HIV-1 particles, soluble regulatory proteins Tat, and inflammatory cytokines released by infected cells could modulate the lytic cycle replication of KSHV.Objective: The objective of the current study was to determine whether overexpression of HIV-1 viral infectivity factor (Vif) mediated by recombinant lentivirus or adenovirus could influence the lytic cycle replication of KSHV in primary effusion lymphoma (PEL) cell lines.Methods: The recombinant lentivirus or adenovirus containing HIV-1 Vif gene was first packaged, respectively, and the viral titer was checked by observing the expression of green fluorescent protein (GFP). The infection efficiency of recombinant virus at different MOIs in target cell (BCBL-1 cells) was tested according to the expression of GFP and Vif protein. After infection with recombinant virus at an appropriate MOI, the mRNA transcription and protein expression of KSHV in BCBL-1 cells were detected by RT-PCR and Western blot, respectively. To examine the effect of Vif expression on KSHV virion release, KSHV DNA in BCBL-1 cells culture supernatant was detected by PCR, the infection efficiency of Vero cells by KSHV virion from the supernatant was also checked. Furthermore, to explore the potential molecular mechanism underlying the effect of Vif on KSHV replication, we tested both ORF50 and ORF73 promoter activity and detected the intracellular signaling pathways, respectively.Results: The recombinant lentivirus and adenovirus with high titer were constructed successfully. BCBL-1 cells could be efficiently infected by the recombinant virus at the MOI of 1, and Vif protein was readily expressed in these cells. The mRNA transcription levels of both T1.1 (lytic gene of KSHV) and ORF26 (encoding KSHV minor capsid protein) in Vif-overexpressed BCBL-1 cells were significantly decreased compared with the corresponding control. Moreover, the protein expression of replication and transcription activator (Rta) and viral interleukin 6 (vIL-6) were down-regulated also. Besides, overexpression of Vif could inhibit the release of the infectious KSHV virion. Mechanistic studies showed that overexpression of Vif resulted in decreased ORF50 promoter activity, interestingly, the ORF73 promoter activity was also attenuated in some degree. The phosphorylation of ERK and GSK-3βwere down-regulated in Vif-overexpressed BCBL-1 cells.Conclusions: Overexpression of Vif in BCBL-1 cells not only inhibited the lytic cycle replication of KSHV, but also repressed the release of the infectious KSHV virion. The inhibition was associated with the regulation of KSHV promoter activity by Vif. ERK MAPK and PI3K/Akt/GSK-3βpathways may play a partial role in modulation of Vif-induced inhibition of KSHV replication. These findings suggest that Vif may participate in the immune escape by inhibiting KSHV lytic replication and play a potential role in KSHV latency infection and KS pathogenesis.Keywords: Vif, KSHV, lytic cycle replication, lentivirus, adenovirus...
Keywords/Search Tags:Vif, KSHV, lytic cycle replication, lentivirus, adenovirus
PDF Full Text Request
Related items
Preliminary Exploration Of Inhibition Of The Lytic Cycle Replication Of Kshv By Viral Infectivity Factor (vif) Of Human Immunodeficiency Virus Type 1 (hiv-1)
The Viral Protein R Of Human Immunodeficiency Virus Type 1 Inhibits The Lytic Cycle Replication Of Kaposi's Sarcoma-Associated Herpesvirus: Role Of GSK-3β Signaling Pathway
Activation Of PI3K/AKT And ERK MAPK Signal Pathways Is Required For The Induction Of Lytic Cycle Replication Of Kaposi’s Sarcoma-Associated Herpesvirus By Herpes Simplex Virus Type1
The Eukaryotic Expression Of Hiv-1 Rev, Its Effect On The Lytic Cycle Replication Of Kshv And The Relationship Between Kshv And Prostate Cancer Cells
Viral modulators of KSHV lytic replication
Human Immunodeficiency Virus Type 1 Vrial Protein R(Vpr) Inhibits The Lytic Cycle Replication Of Kaposi's Sarcoma-Associated Herpesvirus:Role Of Notch/NF-?B Signaling Pathway
Regulation And Mechanism Of Viral Replicative Cycle Of Kaposi's Sarcoma-associated Herpesvirus (kshv) By Regulator Of Virion Protein Expression Of Human Immunodeficiency Virus Type 1 (hiv-1)
Regulation And Mechanism Of Viral Replicative Cycle Of Kaposi's Sarcoma-associated Herpesvirus (KSHV) By Regulator Of Virion Protein Expression Of Human Immunodeficiency Virus Type 1 (HIV-1)
Induction of Markers of DNA Damage Signaling upon Reactivation of Epstein-Barr Virus: A Novel Role for ZEBRA and the Pre-replicative Phase of the Viral Lytic Cycle
10 Cellular genes regulating gammaherpesvirus lytic replication and reactivation